On 22 September 2020, the European Migraine & Headache Alliance organised ‘The Missing Lesson’ webinar to raise awareness about migraine at EU level and kick-start its EU policy advocacy campaign to make migraine a European health priority. The webinar focussed on the medical curriculum deficit when it comes to migraine. This leads to under- diagnosis
Brussels, 23 March 2021 Today, EMHA and the European Parliament Migraine Alliance organised a webinar to raise awareness about the hurdles women with migraine have to overcome and call for action. The call for action is embedded in EMHA’s Policy Paper on ‘Women and Migraine: Bringing women out of the shadows’ that was launched at the
The EMHA worked along KPMG on a market research to understand the patient journey and burden of disease for migraine in 12 countries. The Access to care survey 2021 has shown insightful results on the patients’ access to treatment and care in each of their country. Summary of the “Access To Care III” survey results
REN devices review by CHAMP.Migraine and cluster headache management is complex, as anyone who lives with these diseases can testify. What works for one person may not help another, or may even make their attacks worse. Treatments that were previously successful sometimes stop working for no apparent reason. Even if the treatments do help, there
First monoclonal antibody therapy for prevention of Migraine Aimovig recommended for marketing authorization 01/06/2018 The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Aimovig (erenumab), the first human monoclonal antibody therapy for prevention of migraine. Aimovig belongs to a new class of medicines that work by blocking the activity
Move For Migraine Migraine remains an overlooked and misunderstood condition in many parts of Europe, including Belgium. The disease suffers from a lack of recognition and understanding, even from the first concerned parties (patients, caregivers, employers, etc.). This comes at a significant burden for the patients and at a high cost for society (1,650,000 working
Find out how you can become part of The Migraine Movement and achieve a better future for all the patients living with migraine. For Patients Improving the quality of life of patients by promoting understanding and visibility of their disease. What EMHA can do for patients The Migraine Movement Projects EMHA News For Patients Associations
European survey on migraine in the workplace. Analysis of results and conclusions. The objective of this study is to know the situation of migraine workers within the workplace and compare the situation in the different participating countries. Read de complete document in our Study section About the study of Migraine in the workplace The objective
AEMICE together with Universidad de Sevilla (Seville University) and Novartis and a scientific committee of expert neurologists has created the Migraine Atlas by AEMICE 2018 which reflects the real situation of the 4.5 million people who suffer from migraine in Spain! Unlike other studies “Migraine Atlas” includes the patients and also their families perspective about their condition,
The objective of this study is to know the situation of migraine workers within the workplace and compare the situation in the different participating countries.
European survey.
